Michigan Medicine
Avatar

GI and Hepatic Complications of Cancer Immunotherapy

By Michigan Medicine FEATURING Robert Fontana
By Michigan Medicine FEATURING Robert Fontana
0 views
April 24, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

05:30
Ardelyx

Asking the Right Questions: A Key Step in Treating IBS-C

Feat. J. Ackerman

Featured Video

07:27
Ardelyx

Patient Cases: Making Treatment Decisions in IBS-C

Feat. D. M. Brenner

Recommended

AUTOPLAY
18:57
Masterclasses in Dermatology

Safety and Monitoring Considerations in Systematic Therapy

Feat. J. Cohen
28:32
West Virginia State Rheumatology Society

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

Feat. J. Bustamante
11:43
University of Colorado Department of Medicine

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

Feat. L. Kondapalli
18:46
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

Biomarkers in Immuno-Oncology: Road to Personalized Immunotherapy

Feat. C. Jackson
13:29
Tanaya Shree

The Immunology of Immune Cell Cancers

21:45
International Congress on Cancer Metastasis

Immunotherapy and Targeted Therapy for Personalized Cancer Treatment

Feat. K. Kim
51:29
Masonic Cancer Center, University of Minnesota

The Role of Autologous Transplant and Cellular Therapy for Solid Tum…

Feat. N. Zorko
30:53
Beth Israel Deaconess Medical Center

The Role of the Intestinal Microbiome in Cancer Immunotherapy

Feat. M. Van Den Brink
21:48
Houston Methodist Hospital

Tumor-Infiltrating Lymphocytes for Clinicians

Feat. S. Ganguly
34:35
Beth Israel Deaconess Medical Center

Updates in T-Cell Immunotherapies

Feat. C. Wu
16:27
Insights from 2023 SITC Annual Meeting

SITC 2023 Insights: "AI-Designed Personalized Neoantigen Vaccin…

Feat. D. Kleine-Kohlbrecher
21:43
Yale Cancer Center

The Role of Surgery After Neoadjuvant Systemic Therapy for Cancer

Feat. C. Balch
44:24
McMaster University Department of Medicine

Immune Checkpoint Inhibitor Toxicities in the ICU: A Review

Feat. A. Zereshkian, R. Gerber, L. Spatafora
17:53
Oncology Data Advisor

The Rise of Cancer Immunotherapy: Considerations for Optimal Managem…

Feat. M. Hadfield
48:25
Dana-Farber Cancer Institute

Behind the Breakthroughs: Activating the Immune System to Prevent Ca…

Feat. I. Ghobrial, S. Syngal, M. Yurgelun, B. Ebert
47:26
Moffitt Cancer Center

Basic and Translational Immunotherapy Approaches in Head and Neck Ca…

Feat. R. Uppaluri
16:02
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Proteomic Insights Into Cytokine Release Syndrome and Immune Effecto…

Feat. C. Diorio
45:00
Nebraska Oncology Society

Tissue-Based Predictors of Immunotherapy

Feat. N. Vokes
21:07
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Current Treatments in Langerhans Cell Histiocytosis

Feat. D. TuğCu
51:05
Masonic Cancer Center, University of Minnesota

Therapy-Induced Immunosenescence: Mechanisms, Implications, and Pote…

Feat. B. Zordoky